If you are 18-70 years old, have Type 1 diabetes, feeling depressed, sad, down, hopeless or not experiencing depression you may be eligible to participate in a research study to explore the relationship between diabetes and depression. For more information and to determine eligibility, please call UAB at 975-4208.
You may qualify to participate in an international research study to evaluate the safety and tolerability of an investigational drug for patients with type 2 diabetes and kidney disease. Are you at least 18 years old? Do you have type 2 diabetes mellitus and a clinical diagnosis of kidney disease? Eligible study participants will receive study medications, blood pressure checks, physical exams, laboratory tests and ECG at no cost. Participants will  be reimbursed for time and travel. For more information, call the UAB Hypertension Program at 934-9281 or e-mail ccc-hlnresearch@mail.ad.uab.edu.
The UAB Department of Nutrition Sciences is conducting a 26-week research study to evaluate the effectiveness of an investigational drug to treat Type 2 DM. To qualify, you must be age 19 or older, Type 2 Diabetes, taking Metformin or diet and exercise only to control your blood sugars. Qualified participants will receive study drug, diet/exercise counseling, EKG, Physical and diabetic supplies. There is no charge for participation. Compensation for time and travel may also be available. For more information, and to see if you might be eligible to join, please contact (205)996-4015 or (205)996-4020
You may qualify if you ages 19-45, are African American or European American,  do not have diabetes, exercise less than 2 hours per week, and are willing to travel to UAB for screening and 4 testing visits. Participants will receive their blood sugar level, cholesterol level, bone density, fat mass, and muscle mass. Compensation up to $400 provided for completing all study visits. Please call 934-4386 for more information.
The UAB Diabetes Research Center is part of nationwide study on benefits and risks of four widely used diabetes drugs in combination with metformin.
UAB investigators are studying the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes. Recruitment of volunteers for the project, called the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study, begins in June.

UAB, the City of Birmingham, the YMCA of Greater Birmingham and the American Academy of Family Physicians Foundation team to educate area citizens on diabetes management and prevention.

Actor, performer Ben Vereen lends help to project as community groups begin work to educate populace in overcoming fear of disease

Safety Resources

Sports & Entertainment
Automotive
Retail
Home & Garden
Travel
Dining
Electronics
Health & Beauty